These findings position the OTUD3-IRP2 axis as a promising therapeutic target for preventing iron-mediated neurodegeneration in PD, offering a novel approach to modify disease progression by maintaining proper iron homeostasis. This evidence concerns the gene OTUD3 and Parkinson disease.